Kuehnle raises Series B to ferment a key salmon-feed ingredient
Kuehnle AgroSystems is scaling a non-GMO fermentation process for natural astaxanthin used in aquaculture and nutrition.
Industrial biotech can create value by replacing cultivation-dependent supply chains with more controlled fermentation processes.
What happened
Kuehnle AgroSystems closed a multi-million-dollar Series B led by Ichthus Venture Capital.
S2G Investments, Hatch Blue and new investor Dest EOOD also participated.
The company uses proprietary non-GMO dark fermentation to produce natural astaxanthin, an ingredient used in salmon aquaculture and human nutrition.
The funding supports manufacturing scale-up, regulatory work and commercial development.
Why it matters
Astaxanthin supply is strategically important in aquaculture because the ingredient is widely used in salmon production.
Kuehnle is betting that fermentation can make natural production more scalable and predictable than cultivation-dependent approaches.
The key commercial question is whether manufacturing economics hold as capacity expands.
The bigger picture
Food and agricultural supply chains are increasingly being redesigned through industrial biology.
Fermentation can create more controlled production systems for ingredients that are otherwise constrained by geography, seasonality or resource intensity. Kuehnle fits that broader shift.